Cynthia Ma

2024

Endocrine-Sensitive Disease Rate in Postmenopausal Patients with Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial

Ma, C. X., Suman, V. J., Sanati, S., Vij, K., Anurag, M., Leitch, A. M., Unzeitig, G. W., Hoog, J., Fernandez-Martinez, A., Fan, C., Gibbs, R. A., Watson, M. A., Dockter, T. J., Hahn, O., Guenther, J. M., Caudle, A., Crouch, E., Tiersten, A., Mita, M. & Razaq, W. & 10 others, Hieken, T. J., Wang, Y., Rimawi, M. F., Weiss, A., Winer, E. P., Hunt, K. K., Perou, C. M., Ellis, M. J., Partridge, A. H. & Carey, L. A., Mar 21 2024, In: JAMA oncology. 10, 3, p. 362-371 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

Guo, Z., Luo, J., Jay Mashl, R., Hoog, J., Maiti, P., Fettig, N., Davies, S. R., Aft, R., Held, J. M., Govindan, R., Ding, L., Li, S., von Morze, C., Wulf, G. M., Shoghi, K. I. & Ma, C. X., Jun 2024, In: Cancer research communications. 4, 6, p. 1430-1440 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer

Mayer, E. L., Ren, Y., Wagle, N., Mahtani, R., Ma, C., Demichele, A., Cristofanilli, M., Meisel, J., Miller, K. D., Abdou, Y., Riley, E. C., Qamar, R., Sharma, P., Reid, S., Sinclair, N., Faggen, M., Block, C. C., Ko, N., Partridge, A. H. & Chen, W. Y. & 9 others, Demeo, M., Attaya, V., Okpoebo, A., Alberti, J., Liu, Y., Gauthier, E., Burstein, H. J., Regan, M. M. & Tolaney, S. M., Jun 10 2024, In: Journal of Clinical Oncology. 42, 17, p. 2050-2060 11 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

2023

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

Ademuyiwa, F. O., Northfelt, D. W., O’Connor, T., Levine, E., Luo, J., Tao, Y., Hoog, J., Laury, M. L., Summa, T., Hammerschmidt, T., Guo, Z., Frith, A., Weilbaecher, K., Opyrchal, M., Aft, R., Clifton, K., Suresh, R., Bagegni, N., Hagemann, I. S. & Iglesia, M. D. & 1 others, Ma, C. X., Dec 2023, In: npj Breast Cancer. 9, 1, 1.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma

Wu, Y., Chen, S., Yang, X., Sato, K., Lal, P., Wang, Y., Shinkle, A. T., Wendl, M. C., Primeau, T. M., Zhao, Y., Gould, A., Sun, H., Mudd, J. L., Hoog, J., Mashl, R. J., Wyczalkowski, M. A., Mo, C. K., Liu, R., Herndon, J. M. & Davies, S. R. & 19 others, Liu, D., Ding, X., Evrard, Y. A., Welm, B. E., Lum, D., Koh, M. Y., Welm, A. L., Chuang, J. H., Moscow, J. A., Meric-Bernstam, F., Govindan, R., Li, S., Hsieh, J., Fields, R. C., Lim, K. H., Ma, C. X., Zhang, H., Ding, L. & Chen, F., Dec 15 2023, In: Cancer research. 183, 24, p. 4161-4178 18 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment

Turner, N., Huang-Bartlett, C., Kalinsky, K., Cristofanilli, M., Bianchini, G., Chia, S., Iwata, H., Janni, W., Ma, C. X., Mayer, E. L., Park, Y. H., Fox, S., Liu, X., Mcclain, S. & Bidard, F. C., Mar 1 2023, In: Future Oncology. 19, 8, p. 559-573 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

20 Scopus citations

Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

Hensing, W. L., Gerratana, L., Clifton, K., Medford, A. J., Velimirovic, M., Shah, A. N., Amico, P. D., Reduzzi, C., Zhang, Q., Dai, C. S., Denault, E. N., Bagegni, N. A., Opyrchal, M., Ademuyiwa, F. O., Bose, R., Behdad, A., Ma, C. X., Bardia, A., Cristofanilli, M. & Davis, A. A., Aug 15 2023, In: Clinical Cancer Research. 29, 16, p. 3092-3100 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HRþ)/HER2-Negative Metastatic Breast Cancer

Davis, A. A., Luo, J., Zheng, T., Dai, C., Dong, X., Tan, L., Suresh, R., Ademuyiwa, F. O., Rigden, C., Rearden, T. P., Clifton, K., Weilbaecher, K., Frith, A., Tandra, P. K., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L. F., Peterson, L. L. & Wang, X. & 7 others, Luo, S. J., Zhou, K., Du, P., Jia, S., King, B. L., Krishnamurthy, J. & Ma, C. X., May 1 2023, In: Clinical Cancer Research. 29, 9, p. 1719-1729 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Scopus citations

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

Gerratana, L., Davis, A. A., Velimirovic, M., Clifton, K., Hensing, W. L., Shah, A. N., Dai, C. S., Reduzzi, C., D’Amico, P., Wehbe, F., Medford, A., Wander, S. A., Gradishar, W. J., Behdad, A., Puglisi, F., Ma, C. X., Bardia, A. & Cristofanilli, M., Dec 2023, In: Breast Cancer Research. 25, 1, 112.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Jhaveri, K., Eli, L. D., Wildiers, H., Hurvitz, S. A., Guerrero-Zotano, A., Unni, N., Brufsky, A., Park, H., Waisman, J., Yang, E. S., Spanggaard, I., Reid, S., Burkard, M. E., Vinayak, S., Prat, A., Arnedos, M., Bidard, F. C., Loi, S., Crown, J. & Bhave, M. & 22 others, Piha-Paul, S. A., Suga, J. M., Chia, S., Saura, C., Garcia-Saenz, J., Gambardella, V., de Miguel, M. J., Gal-Yam, E. N., Rapael, A., Stemmer, S. M., Ma, C., Hanker, A. B., Ye, D., Goldman, J. W., Bose, R., Peterson, L., Bell, J. S. K., Frazier, A., DiPrimeo, D., Wong, A., Arteaga, C. L. & Solit, D. B., Oct 2023, In: Annals of Oncology. 34, 10, p. 885-898 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin

Barlin, M., Erdmann-Gilmore, P., Mudd, J. L., Zhang, Q., Seymour, R. W., Guo, Z., Miessner, J. R., Goedegebuure, S. P., Bi, Y., Osorio, O. A., Alexander-Brett, J., Li, S., Ma, C. X., Fields, R. C., Townsend, R. R. & Held, J. M., Jan 2023, In: Molecular and Cellular Proteomics. 22, 1, 100476.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin

Pandurangi, R. S., Cseh, O., Luchman, H. A., Ma, C. X., Senadheera, S. N. & Forrest, M. L., Mar 10 2023, In: ACS Pharmacology and Translational Science. 6, 3, p. 372-386 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer

Bardia, A., Mayer, I., Winer, E., Linden, H. M., Ma, C. X., Parker, B. A., Bellet, M., Arteaga, C. L., Cheeti, S., Gates, M., Chang, C. W., Fredrickson, J., Spoerke, J. M., Moore, H. M., Giltnane, J., Friedman, L. S., Chow Maneval, E., Chan, I. & Jhaveri, K., Jan 2023, In: Breast Cancer Research and Treatment. 197, 2, p. 319-331 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

2022

Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science-Based Study

Housten, A. J., Okere, U. C., Colditz, G. A., Ma, C., Liu, J., Harriss, C., Lin, N. U., Rooney, M., Dill, J., Popalzai, M., Badiu, J., Huang, K., Burton, C. & Peterson, L., Jul 1 2022, In: JMIR Research Protocols. 11, 7, e35736.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer

LoRusso, P., Hamilton, E., Ma, C., Vidula, N., Bagley, R. G., Troy, S., Annett, M., Yu, Z., Conlan, M. G. & Weise, A., Jan 2022, In: Clinical breast cancer. 22, 1, p. 67-77 11 p.

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis

Krishnamurthy, J., Luo, J., Suresh, R., Ademuyiwa, F., Rigden, C., Rearden, T., Clifton, K., Weilbaecher, K., Frith, A., Roshal, A., Tandra, P. K., Cherian, M., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L., Bergqvist, M., Peterson, L. & Ma, C. X., Dec 2022, In: npj Breast Cancer. 8, 1, 35.

Research output: Contribution to journal › Article › peer-review

Open Access

5 Scopus citations

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

Shepherd, J. H., Ballman, K., Polley, M. Y. C., Campbell, J. D., Fan, C., Selitsky, S., Fernandez-Martinez, A., Parker, J. S., Hoadley, K. A., Hu, Z., Li, Y., Soloway, M. G., Spears, P. A., Singh, B., Tolaney, S. M., Somlo, G., Port, E. R., Ma, C., Kuzma, C. & Mamounas, E. & 11 others, Golshan, M., Bellon, J. R., Collyar, D., Hahn, O. M., Hudis, C. A., Winer, E. P., Partridge, A., Hyslop, T., Carey, L. A., Perou, C. M. & Sikov, W. M., Apr 20 2022, In: Journal of Clinical Oncology. 40, 12, p. 1323-1334 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

73 Scopus citations

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

Davis, A. A., Gerratana, L., Clifton, K., Medford, A. J., Velimirovic, M., Hensing, W. L., Bucheit, L., Shah, A. N., D'Amico, P., Reduzzi, C., Zhang, Q., Dai, C. S., Denault, E. N., Bagegni, N. A., Opyrchal, M., Ademuyiwa, F. O., Bose, R., Gradishar, W. J., Behdad, A. & Ma, C. X. & 2 others, Bardia, A. & Cristofanilli, M., Dec 2022, In: EBioMedicine. 86, 104316.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

Suman, V. J., Du, L., Hoskin, T., Anurag, M., Ma, C., Bedrosian, I., Hunt, K. K., Ellis, M. J. & Symmans, W. F., Aug 1 2022, In: Clinical Cancer Research. 28, 15, p. 3287-3295 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

KSTAR: An algorithm to predict patient-specific kinase activities from phosphoproteomic data

Crowl, S., Jordan, B. T., Ahmed, H., Ma, C. X. & Naegle, K. M., Dec 2022, In: Nature communications. 13, 1, 4283.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Risk of Breast Cancer with Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years)

Rahman, T., Sahrmann, J. M., Olsen, M. A., Nickel, K. B., Miller, J. P., Ma, C. & Grucza, R. A., 2022, In: Journal of Clinical Psychopharmacology. 42, 1, p. 7-16 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer

Ma, C. X., Luo, J., Freedman, R. A., Pluard, T. J., Nangia, J. R., Lu, J., Valdez-Albini, F., Cobleigh, M., Jones, J. M., Lin, N. U., Winer, E. P., Kelly Marcom, P., Thomas, S., Anderson, J., Haas, B., Bucheit, L., Bryce, R., Lalani, A. S., Carey, L. A. & Goetz, M. P. & 5 others, Gao, F., Kimmick, G., Pegram, M. D., Ellis, M. J. & Bose, R., Apr 1 2022, In: Clinical Cancer Research. 28, 7, p. 1258-1267 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

35 Scopus citations

2021

A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients

Pillai, S. G., Siddappa, C. M., Ma, C., Snider, J., Kaushal, M., Watson, M. A. & Aft, R., May 2021, In: PloS one. 16, 5 May, e0246139.

Research output: Contribution to journal › Article › peer-review

Open Access

4 Scopus citations

A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment

Pandurangi, R. S., Tomasetti, M., Verapazham, S. T., Paulmurugan, R., Ma, C., Rajput, S., Anjanappa, M. & Nakshatri, H., Feb 2021, In: PloS one. 16, 2 February, e0225869.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

Dehdashti, F., Wu, N., Ma, C. X., Naughton, M. J., Katzenellenbogen, J. A. & Siegel, B. A., Dec 1 2021, In: Nature communications. 12, 1, 733.

Research output: Contribution to journal › Article › peer-review

Open Access

34 Scopus citations

Breast cancer, HER2 mutations, and overcoming drug resistance

Bose, R. & Ma, C. X., Sep 23 2021, In: New England Journal of Medicine. 385, 13, p. 1241-1243 3 p.

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1

Zhu, C., Kim, S. J., Mooradian, A., Wang, F., Li, Z., Holohan, S., Collins, P. L., Wang, K., Guo, Z., Hoog, J., Ma, C. X., Oltz, G., Held, J. M. & Shao, J., Feb 16 2021, In: Cell Reports. 34, 7, 108749.

Research output: Contribution to journal › Article › peer-review

Open Access

12 Scopus citations

CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity

Watt, A. C., Cejas, P., DeCristo, M. J., Metzger-Filho, O., Lam, E. Y. N., Qiu, X., BrinJones, H., Kesten, N., Coulson, R., Font-Tello, A., Lim, K., Vadhi, R., Daniels, V. W., Montero, J., Taing, L., Meyer, C. A., Gilan, O., Bell, C. C., Korthauer, K. D. & Giambartolomei, C. & 13 others, Pasaniuc, B., Seo, J. H., Freedman, M. L., Ma, C., Ellis, M. J., Krop, I., Winer, E., Letai, A., Brown, M., Dawson, M. A., Long, H. W., Zhao, J. J. & Goel, S., Jan 2021, In: Nature Cancer. 2, 1, p. 34-48 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

53 Scopus citations

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer

Kalra, M., Tong, Y., Jones, D. R., Walsh, T., Danso, M. A., Ma, C. X., Silverman, P., King, M. C., Badve, S. S., Perkins, S. M. & Miller, K. D., Dec 2021, In: npj Breast Cancer. 7, 1, 29.

Research output: Contribution to journal › Article › peer-review

Open Access

16 Scopus citations

Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)

Albany, C., Dockter, T., Wolfe, E., Le-Rademacher, J., Wagner-Johnston, N., Einhorn, L., Lafky, J. M., Smith, E., Pachman, D., Staff, N., Ma, C., Loprinzi, C. L. & Costello, B. A., Feb 2021, In: Supportive Care in Cancer. 29, 2, p. 833-840 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

PDXNET Consortium & EurOPDX Consortium, Jan 2021, In: Nature Genetics. 53, 1, p. 86-99 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

122 Scopus citations

Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography

Zhu, Q., Ademuyiwa, F. O., Young, C., Appleton, C., Covington, M. F., Ma, C., Sanati, S., Hagemann, I. S., Mostafa, A., Uddin, K. M. S., Grigsby, I., Frith, A. E., Hernandez-Aya, L. F. & Poplack, S. S., Aug 2021, In: Breast Cancer Research and Treatment. 188, 3, p. 615-630 16 p.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets

Capietto, A. H., Lee, S., Clever, D., Eul, E., Ellis, H., Ma, C. X. & Faccio, R., Dec 2021, In: Cancer immunology research. 9, 12, p. 1400-1412 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

Evaluation of Racial/Ethnic Differences in Treatment and Mortality among Women with Triple-Negative Breast Cancer

Cho, B., Han, Y., Lian, M., Colditz, G. A., Weber, J. D., Ma, C. & Liu, Y., Jul 2021, In: JAMA oncology. 7, 7, p. 1016-1023 8 p.

Research output: Contribution to journal › Article › peer-review

84 Scopus citations

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

Vahdat, L. T., Schmid, P., Forero-Torres, A., Blackwell, K., Telli, M. L., Melisko, M., Möbus, V., Cortes, J., Montero, A. J., Ma, C., Nanda, R., Wright, G. S., He, Y., Hawthorne, T., Bagley, R. G., Halim, A. B., Turner, C. D. & Yardley, D. A., Dec 2021, In: npj Breast Cancer. 7, 1, 57.

Research output: Contribution to journal › Article › peer-review

Open Access

35 Scopus citations

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Ademuyiwa, F. O., Chen, I., Luo, J., Rimawi, M. F., Hagemann, I. S., Fisk, B., Jeffers, G., Skidmore, Z. L., Basu, A., Richters, M., Ma, C. X., Weilbaecher, K., Davis, J., Suresh, R., Peterson, L. L., Bose, R., Bagegni, N., Rigden, C. E., Frith, A. & Rearden, T. P. & 14 others, Hernandez-Aya, L. F., Roshal, A., Clifton, K., Opyrchal, M., Akintola-Ogunremi, O., Lee, B. H., Ferrando-Martinez, S., Church, S. E., Anurag, M., Ellis, M. J., Gao, F., Gillanders, W., Griffith, O. L. & Griffith, M., Aug 2021, In: Breast Cancer Research and Treatment. 189, 1, p. 187-202 16 p.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)

Clifton, K., Luo, J., Tao, Y., Saam, J., Rich, T., Roshal, A., Frith, A., Rigden, C., Ademuyiwa, F., Weilbaecher, K., Hernandez-Aya, L., Peterson, L. L., Bagegni, N., Suresh, R., Bose, R., Opyrchal, M., Wildes, T. M. & Ma, C., Feb 2021, In: Breast Cancer Research and Treatment. 185, 3, p. 639-646 8 p.

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Phase I/II trial of exemestane, ribociclib, and everolimus in women with HR⁺/HER2^- advanced breast cancer after progression on CDK4/6 inhibitors (TRINITI-1)

Bardia, A., Hurvitz, S. A., DeMichele, A., Clark, A. S., Zelnak, A., Yardley, D. A., Karuturi, M., Sanft, T., Blau, S., Hart, L., Ma, C., Rugo, H. S., Purkayastha, D. & Moulder, S., Aug 1 2021, In: Clinical Cancer Research. 27, 15, p. 4177-4185 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

57 Scopus citations

Phase I basket study of taselisib, an isoform-selective PI3K inhibitor, in patients with PIK3CA-mutant cancers

Jhaveri, K., Chang, M. T., Juric, D., Saura, C., Gambardella, V., Melnyk, A., Patel, M. R., Ribrag, V., Ma, C. X., Aljumaily, R., Bedard, P. L., Sachdev, J. C., Dunn, L., Won, H., Bond, J., Jones, S., Savage, H. M., Scaltriti, M., Wilson, T. R. & Wei, M. C. & 1 others, Hyman, D. M., Jan 15 2021, In: Clinical Cancer Research. 27, 2, p. 447-459 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

Phase i Study of Docetaxel and Temsirolimus in Refractory Solid Tumors

Amin, M., Gao, F., Terrero, G., Picus, J., Wang-Gillam, A., Suresh, R., Ma, C., Tan, B., Baggstrom, M., Naughton, M. J., Trull, L., Belanger, S., Fracasso, P. M. & Lockhart, A. C., Sep 2021, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 44, 9, p. 443-448 6 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)

Ligibel, J. A., Huebner, L., Rugo, H. S., Burstein, H. J., Toppmeyer, D. L., Anders, C. K., Ma, C., Barry, W. T., Suman, V., Carey, L. A., Partridge, A. H., Hudis, C. A. & Winer, E. P., Jun 1 2021, In: JNCI Cancer Spectrum. 5, 3, pkab025.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression

Rahman, T., Patrick, C., Ma, C., Nicol, G. E., Reynolds, C. F., Mulsant, B. H., Hartz, S. M., Yingling, M. & Lenze, E. J., 2021, In: Journal of Clinical Psychopharmacology. 41, 1, p. 31-35 5 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies

van de Stolpe, A., Verhaegh, W., Blay, J. Y., Ma, C. X., Pauwels, P., Pegram, M., Prenen, H., De Ruysscher, D., Saba, N. F., Slovin, S. F., Willard-Gallo, K. & Husain, H., Feb 5 2021, In: Frontiers in Genetics. 11, 598118.

Research output: Contribution to journal › Article › peer-review

Open Access

16 Scopus citations

Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy

Magbanua, M. J. M., Hendrix, L. H., Hyslop, T., Barry, W. T., Winer, E. P., Hudis, C., Toppmeyer, D., Carey, L. A., Partridge, A. H., Pierga, J. Y., Fehm, T., Vidal-Martínez, J., Mavroudis, D., Garcia-Saenz, J. A., Stebbing, J., Gazzaniga, P., Manso, L., Zamarchi, R., Antelo, M. L. & Mattos-Arruda, L. D. & 12 others, Generali, D., Caldas, C., Munzone, E., Dirix, L., Delson, A. L., Burstein, H. J., Qadir, M., Ma, C., Scott, J. H., Bidard, F. C., Park, J. W. & Rugo, H. S., Apr 1 2021, In: Journal of the National Cancer Institute. 113, 4, p. 443-452 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

29 Scopus citations

Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy

Griffiths, J. I., Chen, J., Cosgrove, P. A., O’Dea, A., Sharma, P., Ma, C., Trivedi, M., Kalinsky, K., Wisinski, K. B., O’Regan, R., Makhoul, I., Spring, L. M., Bardia, A., Adler, F. R., Cohen, A. L., Chang, J. T., Khan, Q. J. & Bild, A. H., Jun 2021, In: Nature Cancer. 2, 6, p. 658-671 14 p.

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

2020

Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

Dowsett, M., Ellis, M. J., Dixon, J. M., Gluz, O., Robertson, J., Kates, R., Suman, V. J., Turnbull, A. K., Nitz, U., Christgen, M., Kreipe, H., Kuemmel, S., Bliss, J. M., Barry, P., Johnston, S. R., Jacobs, S. A., Ma, C. X., Smith, I. E. & Harbeck, N., Dec 1 2020, In: npj Breast Cancer. 6, 1, 21.

Research output: Contribution to journal › Article › peer-review

Open Access

41 Scopus citations

Microscaled proteogenomic methods for precision oncology

Satpathy, S., Jaehnig, E. J., Krug, K., Kim, B. J., Saltzman, A. B., Chan, D. W., Holloway, K. R., Anurag, M., Huang, C., Singh, P., Gao, A., Namai, N., Dou, Y., Wen, B., Vasaikar, S. V., Mutch, D., Watson, M. A., Ma, C., Ademuyiwa, F. O. & Rimawi, M. F. & 13 others, Schiff, R., Hoog, J., Jacobs, S., Malovannaya, A., Hyslop, T., Clauser, K. R., Mani, D. R., Perou, C. M., Miles, G., Zhang, B., Gillette, M. A., Carr, S. A. & Ellis, M. J., Dec 1 2020, In: Nature communications. 11, 1, 532.

Research output: Contribution to journal › Article › peer-review

Open Access

77 Scopus citations

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

Sachdev, J. C., Munster, P., Northfelt, D. W., Han, H. S., Ma, C., Maxwell, F., Wang, T., Belanger, B., Zhang, B., Moore, Y., Thiagalingam, A. & Anders, C., 2020, (Accepted/In press) In: Breast Cancer Research and Treatment.

Research output: Contribution to journal › Article › peer-review

Open Access

24 Scopus citations

Predictors of distant metastases in triple-negative breast cancer without pathologic complete response after neoadjuvant chemotherapy

Kennedy, W. R., Tricarico, C., Gabani, P., Weiner, A. A., Altman, M. B., Ochoa, L. L., Thomas, M. A., Margenthaler, J. A., Sanati, S., Peterson, L. L., Ma, C. X., Ademuyiwa, F. O. & Zoberi, I., 2020, In: JNCCN Journal of the National Comprehensive Cancer Network. 18, 3, p. 288-296 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

14 Scopus citations

Proteomic resistance biomarkers for pi3k inhibitor in triple negative breast cancer patient-derived xenograft models

Guo, Z., Primeau, T., Luo, J., Zhang, C., Sun, H., Hoog, J., Gao, F., Huang, S., Edwards, D. P., Davies, S. R., Aft, R., Ding, L., Ellis, M. J., Li, S. & Ma, C. X., Dec 2020, In: Cancers. 12, 12, p. 1-14 14 p., 3857.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Cynthia Ma

Research output

Search results